Drug Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Limb Ischemia
Trials Announced for Treatment without Amputation
March 31st, 2000
Endovasc Ltd., Inc., Montgomery, Texas, announced that it would shortly begin Phase III clinical trials of Liprostin for the treatment of critical limb ischemia (CLI), a condition that can be caused by diseases such as diabetes. The announcement was made by the company during a presentation at the Emerging Medical Technology - West Conference in Irvine, California, on March 7, 2000. The Phase III human trials will be conducted under the direction of Dr. Richard M. Smalling, University of Texas Health Science Center in Houston. CLI occurs when the blood circulation in limbs, particularly the legs, becomes so inadequate that that they are in danger of...
Source: Drug Week (2000-03-31)
|
